MedMira Inc. is a biotechnology company, which is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company operates through rapid diagnostic products and services segment. The rapid vertical flow (RVF) technology platform is the basis for the Company's line of rapid tests. Its research is focused on specific areas of the diagnostics market, such as rapid, point-of-care and in vitro sectors. The rapid test applications built on RVF technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases, such as human immunodeficiency virus (HIV) and hepatitis C. Its line of multiplex tests include combination testing solutions for Hepatitis B and C, and Syphilis. The Reveal HP test detects helicobacter pylori (HP) antibodies in serum, plasma or whole blood produced in response to HP infection. The Company's tests are sold under Reveal, Multiplo and Miriad brands in global markets.